IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Foresite Capital Management IV, LLC

Q4 2020 Holdings

Filed 2021-02-16 | 13 holdings | $120.7M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
ALX Oncology Holdings Inc.(ALXO)COM00166B105$83.9M973,51469.5%
Cytokinetics Incorporated(CYTK)COM23282W605$29.8M1,435,99224.7%
Aclaris Therapeutics, Inc.(ACRS)COM00461U105$6.2M951,3845.1%
Kinnate Biopharma Inc.COM49705R105$384.7K9,671,6430.3%
Keros Therapeutics, Inc.(KROS)COM492327101$99.7K1,412,7050.1%
Relay Therapeutics, Inc.(RLAY)COM75943R102$88.9K2,139,3800.1%
Nurix Therapeutics, Inc.(NRIX)COM67080M103$77.2K2,347,8040.1%
Kura Oncology, Inc.(KURA)COM50127T109$59.0K1,807,9820.0%
Olema Pharmaceuticals, Inc.(OLMA)COM68062P106$39.3K818,0300.0%
Generation Bio Co.(GBIOGBX)COM37148K100$24.3K857,9390.0%
Vaxcyte, Inc.(PCVX)COM92243G108$12.4K465,8210.0%
Cymabay Therapeutics, Inc.(CBAYUSD)COM23257D103$10.3K1,787,0940.0%
Therapeutics Acquisition CorpCOM CL A88339T103$4.9K350,0000.0%